Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?

Literature DB >> 18586760

Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?

Jan D Lünemann¹, Christian Münz.

Abstract

Entities: Disease

Mesh：

Year: 2008 PMID： 18586760 DOI： 10.1093/brain/awn132

Source DB: PubMed Journal: Brain ISSN： 0006-8950 Impact factor: 13.501

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Neurotoxicity after CTL019 in a pediatric and young adult cohort.

Authors: Jacqueline S Gofshteyn; Pamela A Shaw; David T Teachey; Stephan A Grupp; Shannon Maude; Brenda Banwell; Fang Chen; Simon F Lacey; Jan J Melenhorst; MacKenzie J Edmonson; Jessica Panzer; David M Barrett; Jennifer L McGuire
Journal: Ann Neurol Date: 2018-09-26 Impact factor: 10.422

Review 2. Fingolimod is a potential novel therapy for multiple sclerosis.

Authors: Orhan Aktas; Patrick Küry; Bernd Kieseier; Hans-Peter Hartung
Journal: Nat Rev Neurol Date: 2010-06-15 Impact factor: 42.937

3. Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.

Authors: Samira Saadoun; Leslie R Bridges; A S Verkman; Marios C Papadopoulos
Journal: Neuroreport Date: 2012-12-19 Impact factor: 1.837

4. Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition.

Authors: Anna Lünemann; Jan D Lünemann; Susanne Roberts; Brady Messmer; Rosa Barreira da Silva; Cedric S Raine; Christian Münz
Journal: J Immunol Date: 2008-11-01 Impact factor: 5.422

Review 5. Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.

Authors: M J Mansilla; S Presas-Rodríguez; A Teniente-Serra; I González-Larreategui; B Quirant-Sánchez; F Fondelli; N Djedovic; D Iwaszkiewicz-Grześ; K Chwojnicki; Đ Miljković; P Trzonkowski; C Ramo-Tello; E M Martínez-Cáceres
Journal: Cell Mol Immunol Date: 2021-05-06 Impact factor: 22.096

6. Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).

Authors: Pascal F Durrenberger; Anna Ettorre; Fatemah Kamel; Louise V Webb; Malcolm Sim; Richard S Nicholas; Omar Malik; Richard Reynolds; Rosemary J Boyton; Daniel M Altmann
Journal: J Neuroinflammation Date: 2012-01-02 Impact factor: 8.322

Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?

1. Neurotoxicity after CTL019 in a pediatric and young adult cohort.

Review 2. Fingolimod is a potential novel therapy for multiple sclerosis.

3. Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.

4. Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition.

Review 5. Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.

6. Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).

Review 7. Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.

Review 8. Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.

Review 9. Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease.

10. Increased HLA-E expression in white matter lesions in multiple sclerosis.